Literature DB >> 1428109

Blood pressure response to hyperinsulinemia in salt-sensitive and salt-resistant rats.

H Tomiyama1, T Kushiro, H Abeta, H Kurumatani, H Taguchi, N Kuga, F Saito, F Kobayashi, Y Otsuka, K Kanmatsuse.   

Abstract

We investigated the role of insulin in salt-sensitive hypertension in Dahl salt-sensitive and salt-resistant rats. The rats were kept in metabolic cages, and sodium intake and urinary sodium excretion were measured. In salt-sensitive rats receiving a 0.3% NaCl diet, sodium retention was significantly greater at weeks 1 and 2 in rats that received an insulin infusion than in those receiving a saline infusion. Mean arterial blood pressure and plasma norepinephrine levels were significantly higher at week 3 in insulin-treated rats than in saline-treated rats (mean arterial pressure, 137 +/- 3 mm Hg versus 119 +/- 3 mm Hg, p < 0.05; plasma norepinephrine, 0.40 +/- 0.02 ng/ml versus 0.27 +/- 0.01 ng/ml, p < 0.05). Insulin did not influence sodium retention, mean arterial pressure, or plasma norepinephrine in salt-resistant rats. Coadministration of an alpha-blocker (bunazosin, 10 mg/kg per day for 3 weeks) in salt-sensitive rats abolished the insulin-induced elevations in mean arterial pressure and sodium retention. When salt-sensitive rats were fed a low salt diet (0.03% NaCl), insulin did not raise mean arterial pressure. Thus, insulin elevated blood pressure only in the salt-sensitive model. The sympathetic nervous system and sodium retention in the early phase of insulin overload may contribute to elevation of mean arterial pressure in this model.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1428109     DOI: 10.1161/01.hyp.20.5.596

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  10 in total

1.  Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin.

Authors:  Kamal Rahmouni; Donald A Morgan; Gina M Morgan; Xuebo Liu; Curt D Sigmund; Allyn L Mark; William G Haynes
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

2.  Selective alpha(1)-adrenoceptor blockade prevents fructose-induced hypertension.

Authors:  Linda T Tran; Kathleen M MacLeod; John H McNeill
Journal:  Mol Cell Biochem       Date:  2014-03-29       Impact factor: 3.396

Review 3.  Hypertension and insulin disorders.

Authors:  Michinori Imazu
Journal:  Curr Hypertens Rep       Date:  2002-12       Impact factor: 5.369

4.  Chronic sodium-retaining action of insulin in diabetic dogs.

Authors:  M Marlina Manhiani; Michael T Cormican; Michael W Brands
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-12

Review 5.  Pathophysiology of the diabetic kidney.

Authors:  Volker Vallon; Radko Komers
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

Review 6.  The inter-relationship between insulin resistance and hypertension.

Authors:  A Salvetti; G Brogi; V Di Legge; G P Bernini
Journal:  Drugs       Date:  1993       Impact factor: 9.546

7.  Role of the IRS-1 and/or -2 in the pathogenesis of insulin resistance in Dahl salt-sensitive (S) rats.

Authors:  Marlene F Shehata
Journal:  Heart Int       Date:  2009-06-30

Review 8.  Carotid body, insulin, and metabolic diseases: unraveling the links.

Authors:  Sílvia V Conde; Joana F Sacramento; Maria P Guarino; Constancio Gonzalez; Ana Obeso; Lucilia N Diogo; Emilia C Monteiro; Maria J Ribeiro
Journal:  Front Physiol       Date:  2014-10-29       Impact factor: 4.566

9.  Important genetic checkpoints for insulin resistance in salt-sensitive (S) Dahl rats.

Authors:  Marlene F Shehata
Journal:  Cardiovasc Diabetol       Date:  2008-06-21       Impact factor: 9.951

Review 10.  Carotid Body and Metabolic Syndrome: Mechanisms and Potential Therapeutic Targets.

Authors:  Lenise J Kim; Vsevolod Y Polotsky
Journal:  Int J Mol Sci       Date:  2020-07-20       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.